Immune-related cutaneous adverse events associated with immune-checkpoint inhibitors: Our experience - 22/08/19
Pinilla-Martín, Belén, Dermatology and Veneorology Department, University Hospital, Madrid, Spain; Sánchez-Velázquez, Alba, Dermatology and Veneorology Department, University Hospital, Madrid, Spain; Vico-Alonso, Cristina, Dermatology and Veneorology Department, University Hospital, Madrid, Spain; Aragón-Miguel, Raquel, Dermatology and Veneorology Department, University Hospital, Madrid, Spain; Calleja- Algarra, Alba, Dermatology and Veneorology Department, University Hospital, Madrid, Spain; Andrés-Lencina, Juan José, Dermatology and Veneorology Department, University Hospital, Madrid, Spain; Burillo-Martínez, Sara, Dermatology and Veneorology Department, University Hospital, Madrid, Spain; Tous-Romero, Fátima, Dermatology and Veneorology Department, University Hospital, Madrid, Spain; Maroñas-Jiménez, Lidia, Dermatology and Veneorology Department, University Hospital, Madrid, Spain; Ortiz-Romero, Pablo Luis, Dermatology and Veneorology Department, University Hospital, Madrid, Spain
Le texte complet de cet article est disponible en PDF. Commercial support: None identified. |
Vol 81 - N° 4S1
P. AB223 - octobre 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?